SCHEMBL23211167

SCHEMBL23211167

O=c1[nH]c(=O)n([N+](=O)[O-])cc1[N+](=O)[O-]

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRIA1 P42261 5/20 0.47
▸ GRIA2 P42262 5/20 0.47
▸ GRIA4 P48058 5/20 0.47
▸ GRIK5 Q16478 3/20 0.47
▸ GRIA3 P42263 4/20 0.42
▸ GRIN2D O15399 3/20 0.42
▸ GRIN3B O60391 3/20 0.42
▸ GRIN1 Q05586 3/20 0.42
▸ GRIN2A Q12879 3/20 0.42
▸ GRIN2B Q13224 3/20 0.42
▸ GRIN2C Q14957 3/20 0.42
▸ GRIN3A Q8TCU5 3/20 0.42
▸ MAPT P10636 3/20 0.42
▸ GRIK1 P39086 2/20 0.42
▸ GRIK2 Q13002 2/20 0.42
▸ GRIK3 Q13003 2/20 0.42
▸ GRIK4 Q16099 2/20 0.42
▸ CYP1A2 P05177 2/20 0.42
▸ LMNA P02545 2/20 0.42
▸ CYP3A4 P08684 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7235118 0.77 GRIA1 (0.47) GRIA1GRIA2GRIA4GRIK5GRIA3
SCHEMBL16174493 0.77 GRIA1 (0.50) GRIA1GRIA2GRIA4GRIK5GRIA3
SCHEMBL22748998 0.73 GRIA1 (0.57) GRIA1GRIA2GRIA4GRIK5GRIA3
SCHEMBL7233498 0.70 GRIA1 (0.58) GRIA1GRIA2GRIA4GRIK5GRIA3
SCHEMBL11708335 0.69 GRIA1 (0.64) GRIA1GRIA2GRIA4GRIK5GRIA3
SCHEMBL16167009 0.69 MAPT (0.43) GRIA1GRIA2GRIA4GRIK5GRIA3
SCHEMBL5846928 0.67 HPGD (0.60) GRIA1GRIA2GRIA4GRIK5MAPT
SCHEMBL10456669 0.66 GRIA1 (0.53) GRIA1GRIA2GRIA4GRIK5TSHR
SCHEMBL5846757 0.65 HPN (0.49) MAPTLMNATSHRKDM4ERAB9A
SCHEMBL23211205 0.65 KMT2A (0.59) GRIA1GRIA2GRIA4GRIK5GRIA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11708336-B2 Anodic oxidation of 5-aminouracil MEDIBEACON INC. (US) 2023-07-25 — — US disclosed
CN-114555087-A Anodic oxidation of 5-aminouracils 麦迪贝肯有限公司 2022-05-27 — — CN disclosed
US-20220002254-A9 ANODIC OXIDATION OF 5-AMINOURACIL MEDIBEACON INC. 2022-01-06 — — US disclosed
WO-2021072159-A1 ANODIC OXIDATION OF 5-AMINOURACIL MEDIBEACON INC. (US) 2021-04-15 — — WO disclosed
US-20210107881-A1 ANODIC OXIDATION OF 5-AMINOURACIL MEDIBEACON INC (US) 2021-04-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11708336-B2 Anodic oxidation of 5-aminouracil DPYD, DHODH, AASDHPPT GRIA1 1936/4885GRIA2 929/4885GRIA4 1387/4885
US-20220002254-A9 ANODIC OXIDATION OF 5-AMINOURACIL DPYD, DHODH, AASDHPPT GRIA1 1936/4885GRIA2 929/4885GRIA4 1387/4885
US-20210107881-A1 ANODIC OXIDATION OF 5-AMINOURACIL DPYD, DHODH, AASDHPPT GRIA1 1936/4885GRIA2 929/4885GRIA4 1387/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback